Non-steroidal anti-inflammatory drugs and clinical outcomes in patients with COVID-19
Article
[키워드] 28-day mortality
Analysis
analyzed
Anti-inflammatory
anti-inflammatory drug
benefit
Clinical outcome
clinical outcomes
clinical status
coronavirus disease
COVID-19
COVID-19 pandemic
decrease
discharge
Evidence
hazard ratio
hospital discharge
Hospitalized
hospitalized patient
In-hospital
medication
Meta-analysis
Mortality
non-steroidal anti-inflammatory drug
Nonsteroidal anti-inflammatory drugs
NSAID
NSAIDS
outcome
Patient
patients with COVID-19
performed
post-hoc
question
raised
receive
risk
Safe
severe COVID-19
severity
significant increase
survival
Treatment
Trial
two group
with COVID-19
[DOI] 10.3389/fcimb.2022.935280 PMC 바로가기
[DOI] 10.3389/fcimb.2022.935280 PMC 바로가기